Farshad Farshidfar
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 5
- Cancer, Lipids, and Metabolism 5
-
- Metabolomics and Mass Spectrometry Studies 10
- Histone Deacetylase Inhibitors Research 3
-
- Analytical Chemistry and Chromatography 2
-
- Traditional Chinese Medicine Studies 2
-
- Cardiovascular Function and Risk Factors 2
- Heart Failure Treatment and Management 2
- Co-authors
- Oliver F. BatheHans J. VogelAalim M. WeljieKaren KopciukAnthony R. MacLeanS. Elizabeth McGregorRobert J. HilsdenW. Donald Buie
- Partner nations
- CanadaUnited StatesIran
In The Last Decade
Farshad Farshidfar
25 papers receiving 704 citations
Peers
Comparison fields: 5 of 102
- Cancer Research 180
- Molecular Biology 456
- Oncology 137
- Spectroscopy 67
- Complementary and alternative medicine 25
Countries citing papers authored by Farshad Farshidfar
This map shows the geographic impact of Farshad Farshidfar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farshad Farshidfar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farshad Farshidfar more than expected).
Fields of papers citing papers by Farshad Farshidfar
This network shows the impact of papers produced by Farshad Farshidfar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farshad Farshidfar. The network helps show where Farshad Farshidfar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Farshad Farshidfar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 24 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 6 | |
| 7 | 2021 | 41 | |
| 8 | 2019 | 9 | |
| 9 | 2019 | 2 | |
| 10 | 2019 | 3 | |
| 11 | 2018 | 32 | |
| 12 | 2017 | 12 | |
| 13 | 2017 | 40 | |
| 14 | 2016 | 111 | |
| 15 | 2016 | 60 | |
| 16 | 2016 | 1 | |
| 17 | 2012 | 86 | |
| 18 | 2009 | 8 | |
| 19 | 2009 | 5 | |
| 20 | 2008 | 25 |
About Farshad Farshidfar
Farshad Farshidfar is a scholar working on Cancer Research, Oncology and Emergency Medicine, having authored 30 papers that have together received 713 indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (10 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer, Lipids, and Metabolism (5 papers), Histone Deacetylase Inhibitors Research (3 papers), Analytical Chemistry and Chromatography (2 papers), Cardiovascular Function and Risk Factors (2 papers), Heart Failure Treatment and Management (2 papers) and Traditional Chinese Medicine Studies (2 papers). The work is most often cited by research in Cancer Research (180 citations), Molecular Biology (456 citations) and Oncology (137 citations). Farshad Farshidfar has collaborated with scholars based in Canada, United States and Iran. Frequent co-authors include Oliver F. Bathe, Hans J. Vogel, Aalim M. Weljie, Karen Kopciuk, Anthony R. MacLean, S. Elizabeth McGregor, Robert J. Hilsden, W. Donald Buie, Francis Sutherland and Elijah Dixon. Their work appears in journals such as Circulation, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.